World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
Open accessThe DOI matches its Crossref record.
Abstract
The proliferation of antimalarial drug trials in the last ten years provides the opportunity to launch a concerted global surveillance effort to monitor antimalarial drug efficacy. The diversity of clinical study designs and analytical methods undermines the current ability to achieve this. The proposed World Antimalarial Resistance Network (WARN) aims to establish a comprehensive clinical database from which standardised estimates of antimalarial efficacy can be derived and monitored over time from diverse geographical and endemic regions. The emphasis of this initiative is on five key variables which define the therapeutic response. Ensuring that these data are collected at the individual patient level in a consistent format will facilitate better data management and analytical practices, and ensure that clinical data can be readily collated and made amenable for pooled analyses. Such an approach, if widely adopted will permit accurate and timely recognition of trends in drug efficacy. This will guide not only appropriate interventions to deal with established multidrug resistant strains of malaria, but also facilitate prompt action when new strains of drug resistant plasmodia first emerge. A comprehensive global database incorporating the key determinants of the clinical response with in vitro, molecular and pharmacokinetic parameters will bring together relevant data on host, drug and parasite factors that are fundamental contributors to treatment efficacy. This resource will help guide rational drug policies that optimize antimalarial drug use, in the hope that the emergence and spread of resistance to new drugs can be, if not prevented, at least delayed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Rijal, S., Ostyn, B., Uranw, S., Rai, K., Bhattarai, N. R., Dorlo, T. P. C., Beijnen, J. H., Vanaerschot, M., Decuypere, S., Dhakal, S. S., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit102 · Cited by 319
A Research Agenda for Malaria Eradication: Drugs
The malERA Consultative Group on Drugs (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000402 · Cited by 288
Nanotechnology applied to the treatment of malaria
Santos-Magalhães, N. S., & Mosqueira, V. C. F. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.024 · Cited by 286
McGready, R., Tan, S. O., Ashley, E. A., Pimanpanarak, M., Viladpai-nguen, J., Phaiphun, L., Wüstefeld, K., Barends, M., Laochan, N., Keereecharoen, L., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050253 · Cited by 136
“This study shows that guidelines for defining antimalarial efficacy [40,41] in non-pregnant patients may not be applicable to pregnancy.”
BackgroundSelf-citationSridaran, S., McClintock, S. K., Syphard, L. M., Herman, K. M., Barnwell, J. W., & Udhayakumar, V. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-247 · Cited by 124
“However, clinical efficacy trials are resource-intensive, making them difficult to use broadly for surveillance purposes, reviewed in [11].”
Background
Metadata
- Authors
- Price, R. N., Dorsey, G., Ashley, E. A., Barnes, K. I., Baird, J. K., d'Alessandro, U., Guerin, P. J., Laufer, M. K., Naidoo, I., Nosten, F., Olliaro, P., Plowe, C. V., Ringwald, P., Sibley, C. H., Stepniewska, K., & White, N. J.
- Venue
- Malaria Journal
- Published
- 2007-09-06
- Volume
- 6
- Issue
- 1
- Pages
- 119-119
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W2118288290
- Cited by
- 69
- References
- 0
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs. https://app.cochat.ai/papers/10.1186/1475-2875-6-119
- The paper
- Price, R. N., Dorsey, G., Ashley, E. A., Barnes, K. I., Baird, J. K., d'Alessandro, U., Guerin, P. J., Laufer, M. K., Naidoo, I., Nosten, F., Olliaro, P., Plowe, C. V., Ringwald, P., Sibley, C. H., Stepniewska, K., & White, N. J. (2007). World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs. Malaria Journal. https://doi.org/10.1186/1475-2875-6-119
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.